Carpmaels escapes €1bn claim in BASF patent row

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

Carpmaels escapes €1bn claim in BASF patent row

c0a6c8dd-7096-4a29-82d8-63ce4a28fe8bhigh-court-mw-600-comp.jpg

Shakespearean analogies fail to convince High Court that BASF’s €1bn claim has merit as company awarded only ‘nominal’ damages in Carpmaels patent row

Carpmaels & Ransford has escaped a major damages claim in the England and Wales High Court after German company BASF unsuccessfully claimed the firm’s negligence resulted in the company suffering €1.05bn ($1.2bn) in lost profits.

In a judgment yesterday, October 29, Mr Justice Adam Johnson ruled that BASF should be entitled to only “nominal damages” after Carpmaels missed a deadline for filing an appeal against a patent revocation.

Those damages will be decided at a later date. The final amount could range anywhere between just a few pounds and several hundred pounds.

Carpmaels had already admitted it was responsible for the loss of the appeal but contended that the appeal had little chance of success.

The numbers claimed in the trial, which began in April this year, were eye watering. BASF alleged that the total loss of profits it suffered from Carpmaels missing the deadline to appeal was €1.05 billion.

Although BASF argued these were its calculated losses, it invited the court to conclude the precise losses suffered.

The dispute centred on European patent 1,663,458 (‘458 patent) which, according to the claim, occupied “vital space” in relation to complying with diesel emission standards.

BASF contended that Carpmaels, which admitted negligence on its part, failed to file an appeal in time after the EPO revoked the ‘458 patent in 2012.

BASF said that had the appeal succeeded, the revocation would never have taken effect and the company would have had a valid patent until July 2024.

It added that it would have been able to seek damages from other competitors adjudged to have allegedly infringed the ‘458 patent, and could have cemented itself as a “market leader at a crucial time for NOx emissions products”.

However, Mr Justice Johnson was unconvinced.

“I am not persuaded that overall the claimants lost any real chance of achieving greater awards of business or negotiating more favourable licence terms,” he found.

The judgment came despite the best efforts of BASF’s counsel Roger Stewart QC, who during proceedings quoted Brutus in William Shakespeare’s Julius Caesar, exclaiming: “There is a tide in the affairs of men, which, taken at the flood, leads on to fortune.”

Johnson said: “According to Mr Stewart QC, the tide would have been in for the claimants. Because of Carpmaels’ negligence, they missed it.”

The judge agreed with Carpmaels’ defence, namely that any appeal against the patent’s validity was unlikely to succeed in the first place.

“The likelihood of BASF’s case succeeding on its appeal was less than 50/50,” Johnson found. 

“While accepting that there were arguments in both directions, including arguments in favour of validity which could be (and were) properly made, I am persuaded that there were fundamental difficulties with the ‘458 patent which, overall, would have made it less likely than not that any appeal would succeed.”

He added: “My overall assessment is that the claimants are entitled only to nominal damages resulting from Carpmaels’ admitted breach.”

Stewart QC and Pippa Manby of 4 New Square and Miles Copeland of Three New Square, instructed by Reed Smith, acted for BASF. John Wardell QC of Wilberforce Chambers, Henry Ward of 8 New Square and Nick Zweck of Hogarth Chambers, instructed by Clyde & Co, represented Carpmaels & Ransford.

more from across site and SHARED ros bottom lb

More from across our site

McDermott Will & Schulte lawyers explore why the UPC is seeing rapid adoption by medtech for fast-moving disputes, while pharma and biotech take a cautious, selective approach over revocation risks
IP firms may be growing more comfortable with external capital, but uncertainty over who could ultimately own the business is complicating the investment pitch
The former Western District of Texas judge addresses perceptions of his courtroom, reveals what comes next as he returns to practice at A&O Shearman and explains why marathon running is ‘cathartic’
International Anti-Counterfeiting Coalition says it has been blocked from hosting its annual event in the city, ending a long tradition of holding the gathering in the days leading up to INTA’s flagship event
The ITC is a powerful tool for litigators, practitioners say, as the threat of an exclusion order on a critical tech component could mean disrupting the entire data centre's operations
Anna Toh plans to expand Rajah & Tann’s soft IP capabilities, leveraging its Southeast Asia network to support clients on cross-border portfolio management and commercial strategy
The Canadian boutique’s new IP lead says he wants to build a tech-enabled IP practice aimed at giving startups senior expertise away from the traditional ‘big law’ set-up
Qantm IP’s acquisition of Henry Goh & Co shows shifting attitudes towards private equity, with firms increasingly viewing external backing as a normal route to expansion rather than a source of concern
The firm’s involvement in prominent AI cases drew litigator Christian Mammen to join from Womble Bond Dickinson, as US firms continue to bolster AI-focused practices
Two judicial appointments confirmed in Paris and Mannheim, while cross-border injunctions and high-profile procedural rulings keep major patent practices occupied
Gift this article